Pagaya shares have dipped considerably since the company’s earnings release. Pagaya has long had a trading pattern that is close to indecipherable as well as the remnants of a legacy ownership base who have used liquidity events to sell shares. It remains underfollowed by brokerage analysts. The quarter and the outlook were what they were…
We made some changes in the high growth portfolio this morning. We sold a bit more than half of our Xometry position at the opening and got $44.39. We sold 900 shares, leaving 700 in the portfolio of 1.59. I will reconsider the position as it is too small on a permanent basis in the…
Lots of companies have reported their Q2 results-several hundred in fact. Within our high growth portfolio 4 companies out of 8 scheduled to report this week have now done so. For the most part, the earnings reports emerging range from good to excellent. Q2 is shaping up to have been a better quarter for software…
AS we had discussed in this week’s commentary, we believed that the recent appreciation of IT stocks had taken some of the positions in the portfolio to valuations that were a bit stressed. Today, that opinion was seconded by the analyst team at Raymond James with regards to Nutanix. That precipitated our sale of a…
Summary Xometry’s AI-powered marketplace is uniquely positioned to benefit from supply chain reshoring and tariff-driven sourcing complexity, driving accelerating growth. Recent earnings show robust revenue growth and raised guidance, yet the stock trades at a compressed valuation, offering significant upside potential. Despite macro uncertainty, Xometry’s solutions are increasingly relevant for enterprise customers seeking procurement efficiency…
A bit of alliteration-perhaps intentional. I have gotten more than a few questions on what tariffs will mean for the market-and very specifically the Ticker Target High Growth portfolio. In the short term I imagine the impact is obvious. The Ticker Target high growth portfolio has fallen about 17% since it hit a high little…
We have made the following changes in the high growth portfolio earlier this morning. CompanySharesPriceB/STotalOld Position New PositionWeightSprount Social1,500$66.69S$40,0251,50000%Datadog120$117.01S$14,02512000%Braze800$37.49B$30,00008003.5%Xometry300$27.69B$8,3151,2001,5003.4%Unity400$26.59B$10,6451,3001,7003.7%Procore50$79.49B$3,9805506003.9% Sprout Social reported yet another disappointing quarter with revenue growth forecasted at 10% for the full year. The company continues to report growth in bookings in the mid-high 20% range but somehow the bookings never translate into revenue…
There has been lots of volatility since Monday. First the DeepSeek panic and then yesterday the sharp reversal as investors started to refine their view of the likely impact of the cost of cheaper models. Today-at least as I write this-seems to be presenting a bit of a consolidation trade after yesterday’s sharp spike. …
Shift4 Earlier today we sold a bit more than half our position Shift4. We have had a sizable position-1100 shares-and we were able to sell 600 shares before the price declined below our limit. The average price of our sale was $105.77, and the low price was $103.99. Today, the CEO of the company, Jared Isaacman, accepted…
Summary Xometry, an AI-enabled B2B marketplace for manufacturing procurement, offers a significant growth runway and a well-defined path to non-GAAP profitability and free cash flow generation. The company’s use of AI for optimized matching and instant quotes creates a competitive moat, driving substantial revenue growth from existing customers. Despite a conservative guidance approach, Xometry’s valuation…